pharmaphorum Podcast

Having any chronic health condition is complicated, difficult, and scary. But add in a cultural or social stigma and you create whole new levels of challenge.  In today’s pharmaphorum podcast, brought to you by Cerner Enviza, an Oracle company, editor in chief Jonah Comstock welcomes Nate Way, senior evidence generation lead at Cerner Enviza and James Geary MBA, MHA, a data analyst who also lives...

In this latest mini pharmaphorum podcast, web editor Nicole Raleigh spoke with Tommy Bramley, SVP of global consulting at Amerisource Bergen, whilst attending Reuters Pharma Barcelona.

On today’s pharmaphorum podcast, Evidation’s Executive Chair of the Board Deborah Kilpatrick joins host Jonah Comstock to talk about healthcare data collection in 2023 and how it intersects with stakeholders across the ecosystem, from tech and pharma companies to research participants. 

In this new episode of the mini pharmaphorum podcast, web editor Nicole Raleigh spoke with Simon Powell, CEO of Ribonexus, a new company put together to develop and ultimately commercialise long-standing research programmes from Gustav Roussy, Institut Curie, the University of Strasbourg, and Pierre Fabre, to develop drugs that overcome tumour resistance to existing drug treatments.

In today’s pharmaphorum podcast, brought to you by Lannett Corporation, editor in chief Jonah Comstock first chats with Timothy Crew, CEO of Lannett. Crew talks about the contract development manufacturing organisation (CDMO) business and why local manufacturing is important in the United States. Then, in part 2, Jonah talks to Tom Lewis, Lannett’s VP of Global Supply Chain and CDMO Management. Th...

Almost everyone seems to agree that drug prices are too high. But that agreement stops when it comes to the question of why they’re so high, and to the question of how to bring them down.  Goodroot CEO Mike Waterbury and Nuwae Health CEO Ralph Pisano discuss how the community of Goodroot companies, including Nuwae, are attacking that issue from different angles. 

Angelini Ventures is a recently launched investment fund seeking companies that are transformational in healthcare. Founder of pharmaphorum and Healthware Group's chief content officer, Paul Tunnah, talks with Nils Bottler, who recently joined Angelini Ventures as Principal, about his career and where Angelini Ventures aims to have an impact.

For the newest pharmaphorum podcast, editor in chief Jonah Comstock welcomes Dr. Kristina Allikmets, SVP and head of R&D at Takeda’s plasma-derived therapies business unit. 

In this episode of the pharmaphorum podcast, host Jonah Comstock welcomes Marc de Garidel, CEO of CinCor Pharma, which was just recently sold to AstraZeneca for more than $1 billion USD. Marc tells Jonah all about CinCor and its unique approach to hypertension, how the AstraZeneca deal came about, and what happens next.

No matter what industry you’re in, artificial intelligence is a major topic around the water cooler. But while AI in popular culture may be at a peak of hype, AI in pharma is strending toward a moment of maturity, reliability, and scalability. In today’s pharmaphorum podcast, brought to you by Syneos Health, Leigh Householder, EVP and MD technology and data solutions at Syneos Health and Noolie Gr...

At the beginning of February, pharmaphorum web editor Nicole Raleigh travelled to Rome to cover the inaugural VITA Accelerator demo day. After the event, VITA’s senior programme manager Anastasiya Markvarde and managing director Paolo Borella took time to discuss the ethos behind the accelerator and the future of digital health start-ups in Italy and beyond.

Angelini Ventures is a recently launched investment fund seeking companies that are transformational in healthcare. pharmaphorum founder and Healthware Chief Content Officer Paul Tunnah, talks with co-Managing Director Elia Stupka about the new €300 million fund, how it started, how it’s going, and what health innovation looks like from the investor’s perspective. This podcast was produced in part...

 This time around on the pharmaphorum podcast, Editor in Chief Jonah Comstock chats with Nathan Buchbinder, cofounder and chief product officer at Proscia about pathology data, why it has taken so long to digitise it, and what the possibilities are when this data is freed from its historical siloes. 

In the newest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Jameka Hill, senior director of clinical trial health equity at Moderna. 

pharmaphorum Editor-in-Chief Jonah Comstock and pharmaphorum Founder Paul Tunnah headed to San Francisco this week for the JP Morgan conference, the annual elbow-rubbing opportunity for biotech bigwigs. This is the first time the show has been back in person since COVID, and, despite some less than ideal weather, attendees were excited to resume in person collaboration.

During The Economist’s 8th Annual World Cancer Series congress in Brussels last month, web editor Nicole Raleigh sat down to discuss the event and its themes with Greg Rossi, senior vice president, head of oncology Europe and Canada at AstraZeneca .

Speaking with Rob Verheul, CEO of Graphite Digital, at Anthropy 2022 at the Eden Project, pharmaphorum web editor Nicole Raleigh enjoyed a minute discussing the event and what specifically had attracted Verheul to attend.

As we close out the year, the pharmaphorum editorial team sits down together for a roundtable discussion of some of the biggest trends they’ve tracked this year in the world of pharma. 

While at Anthropy 2022, pharmaphorum’s web editor Nicole Raleigh briefly spoke with Karyn Johnston, chief executive of East Cheshire Hospice, who had taken part in the Adelphi Group’s panel, ‘Later life care and dementia’.

Following an invite to fly into Parma, Italy to witness first-hand the press launch of the considerable structure that is the Chiesi Group’s new €85 million Biotech Centre of Excellence, pharmaphorum web editor Nicole Raleigh spoke with Chiesi’s head of global manufacturing, Antonio Magnelli.

On today’s pharmaphorum podcast, host Jonah Comstock takes us to the PharmStars presentation last month at the Boston Seaport, with interviews conducted at the event. The topic: Innovations in Real-World Evidence. 

Flying into London recently for the Jefferies Conference, Novavax’s EVP, chief commercial officer, and chief business officer John Trizzino, together with the company’s chief medical officer Filip Dubovsky, took time out of very packed schedules indeed to speak with pharmaphorum Web editor Nicole Raleigh in a small (though not always necessarily quiet) corner of the One Aldwych Hotel on the Strand...

In the newest episode of the pharmaphorum podcast, editor in chief Jonah Comstock chats with Gita Barry, EVP and GM of Immersive Healthcare at Penumbra, a therapeutic VR company.

Anthropy 2022 brought climate change to industry in Cornwall in (a very wet and windy) early November, settling cosily into the truly eco-minded environs of the Eden Project and firing up fervent and necessary conversations on sustainability, accessibility, and action plans. Amidst all this, Adelphi Group’s CEO Stuart Cooper found a moment to sit with pharmaphorum web editor Nicole Raleigh and dis...

pharmaphorum Editor-in-Chief Jonah Comstock traveled to Las Vegas last week with thousands of other healthcare stakeholders for the HLTH 2022 conference. In this post-show edition of the pharmaphorum podcast, Jonah welcomes Matthew Holt, editor of The Healthcare Blog and former digital health event organiser, to discuss the show itself and the content therein.